top of page
BioWorks Pharmaceuticals
We at BioWorks Pharmaceuticals are developing Phenixmab, to target advanced non-small cell lung cancer. Phenixmab has demonstrated reduced proliferation in lung cancer cells, serving as a potential therapy.
bottom of page